Clonal evolution of glioblastoma under therapy
暂无分享,去创建一个
In-Hee Lee | Raul Rabadan | Andrew J Blumberg | Francesco Abate | Do-Hyun Nam | Daniel I. S. Rosenbloom | Oliver Elliott | Woong-Yang Park | Antonio Iavarone | Zhaoqi Liu | Erik Ladewig | Sakellarios Zairis | Anna Lasorella | Veronique Frattini | Jiguang Wang | A. Blumberg | A. Iavarone | Daniel I S Rosenbloom | R. Rabadán | In-Hee Lee | D. Nam | W. Park | G. Finocchiaro | M. Eoli | A. Lasorella | Zhaoqi Liu | V. Frattini | Jiguang Wang | Oliver Elliott | Emanuela Cazzato | Erik Ladewig | Sakellarios Zairis | F. Abate | Y. Shin | Jin-Ku Lee | Gaetano Finocchiaro | Marica Eoli | Jin-Ku Lee | Emanuela Cazzato | Yong-Jae Shin | In‐Hee Lee
[1] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[2] P. Armitage,et al. The age distribution of cancer and a multi-stage theory of carcinogenesis , 1954, British Journal of Cancer.
[3] C. Nordling. A New Theory on the Cancer-inducing Mechanism , 1953, British Journal of Cancer.
[4] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[5] Trevor Bedford,et al. Overdispersion of the molecular clock: temporal variation of gene-specific substitution rates in Drosophila. , 2008, Molecular biology and evolution.
[6] J. Baselga,et al. TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.
[7] Luca Laurenti,et al. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia , 2014, eLife.
[8] D. Mercola,et al. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] Tracy T Batchelor,et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. , 2006, Cancer research.
[10] T. Golub,et al. The Genomic Landscape of Juvenile Myelomonocytic Leukemia , 2015, Nature Genetics.
[11] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[12] A. Iavarone,et al. Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma , 2015, Clinical Cancer Research.
[13] Raul Rabadan,et al. MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples , 2013, BMC Systems Biology.
[14] D. Bigner,et al. EGF mutant receptor vIII as a molecular target in cancer therapy. , 2001, Endocrine-related cancer.
[15] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[16] J. Otte,et al. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. , 2002, Genes & development.
[17] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[18] Raul Rabadan,et al. SAVI: a statistical algorithm for variant frequency identification , 2013, BMC Systems Biology.
[19] K. Miyazono,et al. A role of the latent TGF‐beta 1‐binding protein in the assembly and secretion of TGF‐beta 1. , 1991, The EMBO journal.
[20] A. Iavarone,et al. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein , 2008, Nature Cell Biology.
[21] Jill S Barnholtz-Sloan,et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution , 2015, Genome research.
[22] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[23] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[24] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[25] V. Balasubramaniyan,et al. TGF-β as a therapeutic target in high grade gliomas - promises and challenges. , 2013, Biochemical pharmacology.
[26] Raul Rabadan,et al. An information theoretic method to identify combinations of genomic alterations that promote glioblastoma. , 2015, Journal of molecular cell biology.
[27] A. Verma. MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma , 2006 .
[28] Stephen Yip,et al. MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance , 2009, Clinical Cancer Research.
[29] J. Uhm. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .
[30] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[31] Robert J Dempsey,et al. Science Times , 2022 .
[32] Chibo Hong,et al. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. , 2015, Cancer cell.
[33] Raul Rabadan,et al. The integrated landscape of driver genomic alterations in glioblastoma , 2013, Nature Genetics.
[34] Chris Wiggins,et al. Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer , 2014, BMC Systems Biology.
[35] T. D. Schneider,et al. Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.
[36] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[37] Satoru Miyano,et al. Mutational landscape and clonal architecture in grade II and III gliomas , 2015, Nature Genetics.
[38] B. Kamińska,et al. TGF beta signaling and its role in glioma pathogenesis. , 2013, Advances in experimental medicine and biology.
[39] K. Aldape,et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. , 2013, The Journal of clinical investigation.
[40] Zoltan Szallasi,et al. In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census , 2012, Oncoimmunology.
[41] Peter Canoll,et al. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma , 2014, Proceedings of the National Academy of Sciences.
[42] Rebecca A Betensky,et al. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.
[43] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[44] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[45] Peter J. Campbell,et al. Evolution of the cancer genome , 2012, Nature Reviews Genetics.
[46] K. Hoang-Xuan,et al. Primary brain tumours in adults , 2003, The Lancet.
[47] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[48] Nordling Co. A New Theory on the Cancer-inducing Mechanism , 1953 .
[49] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[50] Trevor Bedford,et al. Overdispersion of the Molecular Clock Varies Between Yeast, Drosophila and Mammals , 2008, Genetics.
[51] J. Uhm,et al. The transcriptional network for mesenchymal transformation of brain tumours , 2010 .
[52] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[53] Andrew J. Blumberg,et al. Moduli Spaces of Phylogenetic Trees Describing Tumor Evolutionary Patterns , 2014, Brain Informatics and Health.
[54] Christopher A. Maher,et al. ChimeraScan: a tool for identifying chimeric transcription in sequencing data , 2011, Bioinform..
[55] Qi-En Wang,et al. Review Article TGF-β signaling and its targeting for glioma treatment , 2015 .
[56] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[57] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[58] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[59] E. E. Gresch. Genetic Alterations During Colorectal-Tumor Development , 1989 .
[60] In-Hee Lee,et al. Spatiotemporal Evolution of the Primary Glioblastoma Genome. , 2015, Cancer cell.
[61] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[62] B. Giusti,et al. EXCAVATOR: detecting copy number variants from whole-exome sequencing data , 2013, Genome Biology.
[63] John N. Weinstein,et al. PRADA: pipeline for RNA sequencing data analysis , 2014, Bioinform..
[64] D. Brat,et al. Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma , 2012, Science.